We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What's in Store for Science Applications (SAIC) 4Q Earnings?
Read MoreHide Full Article
Science Applications International Corporation (SAIC - Free Report) is set to report fourth-quarter fiscal 2021 earnings on Mar 25.
The company’s earnings surpassed the Zacks Consensus Estimate in three of the trailing four quarters and missed in the remaining one, the average surprise being 9.6%.
For the fiscal fourth quarter, the Zacks Consensus Estimate for revenues is pegged at $1.73 billion, indicating a 12.4% improvement from the year-ago quarter’s reported figure. For earnings, the consensus mark stands at $1.43 per share, suggesting a decline of 9.5% from the prior-year quarter’s reported number.
Let’s see how things have shaped up for the upcoming announcement.
Factors at Play
Science Applications’ fourth-quarter fiscal 2021 results are likely to reflect a strong product portfolio, which has been aiding contract wins. The company’s capability to sustain its existing contracts along with the newly awarded ones across the customer portfolio is likely to have acted as a tailwind.
Science Applications International Corporation Price and Consensus
Notably, the company won more than $1.9 billion in national security contracts during the fourth quarter, which gives us an idea about its upcoming performance report.
Moreover, the acquisitions of Engility and Unisys Federal are expected to have been the key drivers of fiscal fourth-quarter earnings. The buyouts are also likely to have boosted the company’s margin profile and cash-flow generation.
Additionally, strong demand for the company’s IT modernization services, which include advanced analytics, software and app modernization, and cloud migration, may have been a key catalyst.
The company, last year, introduced the SAIC R3 portfolio of solutions to enable government agencies to meet the new work challenges posed by the coronavirus-led work-from-home environment. This is expected to have widened the company’s portfolio bandwidth and driven user acquisition.
However, the COVID-19 pandemic is likely to hurt Science Applications’ top and bottom lines in the fourth quarter. In its last earnings call, the company had stated that the pandemic will negatively impact its fiscal 2021 revenues and profits by $250 million and $35 million, respectively.
What Our Model Says
Our proven model predicts an earnings beat for Science Applications this time around. The combination of a positive Earnings ESP, and Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold), increases the chances of an earnings beat. You can uncover the best stocks to buy or sell, before they’re reported, with our Earnings ESP Filter.
Science Applications currently carries a Zacks Rank of 3 (Hold) and has an Earnings ESP of +5.35%.
Other Stocks With Favorable Combinations
Here are some other companies, which, per our model, have the right combination of elements to post earnings beats this quarter:
Evolus, Inc. (EOLS - Free Report) has an Earnings ESP of +35.39% and holds a Zacks Rank of 3, currently.
IHS Markit Ltd. has an Earnings ESP of +1.02% and carries a Zacks Rank of 3 at present.
Zacks Top 10 Stocks for 2021
In addition to the stocks discussed above, would you like to know about our 10 best buy-and-hold tickers for the entirety of 2021?
Last year's 2020 Zacks Top 10 Stocks portfolio returned gains as high as +386.8%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Image: Shutterstock
What's in Store for Science Applications (SAIC) 4Q Earnings?
Science Applications International Corporation (SAIC - Free Report) is set to report fourth-quarter fiscal 2021 earnings on Mar 25.
The company’s earnings surpassed the Zacks Consensus Estimate in three of the trailing four quarters and missed in the remaining one, the average surprise being 9.6%.
For the fiscal fourth quarter, the Zacks Consensus Estimate for revenues is pegged at $1.73 billion, indicating a 12.4% improvement from the year-ago quarter’s reported figure. For earnings, the consensus mark stands at $1.43 per share, suggesting a decline of 9.5% from the prior-year quarter’s reported number.
Let’s see how things have shaped up for the upcoming announcement.
Factors at Play
Science Applications’ fourth-quarter fiscal 2021 results are likely to reflect a strong product portfolio, which has been aiding contract wins. The company’s capability to sustain its existing contracts along with the newly awarded ones across the customer portfolio is likely to have acted as a tailwind.
Science Applications International Corporation Price and Consensus
Science Applications International Corporation price-consensus-chart | Science Applications International Corporation Quote
Notably, the company won more than $1.9 billion in national security contracts during the fourth quarter, which gives us an idea about its upcoming performance report.
Moreover, the acquisitions of Engility and Unisys Federal are expected to have been the key drivers of fiscal fourth-quarter earnings. The buyouts are also likely to have boosted the company’s margin profile and cash-flow generation.
Additionally, strong demand for the company’s IT modernization services, which include advanced analytics, software and app modernization, and cloud migration, may have been a key catalyst.
The company, last year, introduced the SAIC R3 portfolio of solutions to enable government agencies to meet the new work challenges posed by the coronavirus-led work-from-home environment. This is expected to have widened the company’s portfolio bandwidth and driven user acquisition.
However, the COVID-19 pandemic is likely to hurt Science Applications’ top and bottom lines in the fourth quarter. In its last earnings call, the company had stated that the pandemic will negatively impact its fiscal 2021 revenues and profits by $250 million and $35 million, respectively.
What Our Model Says
Our proven model predicts an earnings beat for Science Applications this time around. The combination of a positive Earnings ESP, and Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold), increases the chances of an earnings beat. You can uncover the best stocks to buy or sell, before they’re reported, with our Earnings ESP Filter.
Science Applications currently carries a Zacks Rank of 3 (Hold) and has an Earnings ESP of +5.35%.
Other Stocks With Favorable Combinations
Here are some other companies, which, per our model, have the right combination of elements to post earnings beats this quarter:
Winnebago Industries, Inc. (WGO - Free Report) has an Earnings ESP of +7.69% and carries a Zacks Rank of 2, at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Evolus, Inc. (EOLS - Free Report) has an Earnings ESP of +35.39% and holds a Zacks Rank of 3, currently.
IHS Markit Ltd. has an Earnings ESP of +1.02% and carries a Zacks Rank of 3 at present.
Zacks Top 10 Stocks for 2021
In addition to the stocks discussed above, would you like to know about our 10 best buy-and-hold tickers for the entirety of 2021?
Last year's 2020 Zacks Top 10 Stocks portfolio returned gains as high as +386.8%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Access Zacks Top 10 Stocks for 2021 today >>